Platelet activation and platelet-monocyte interaction amplify thromboinflammation in obesity through adhesion

Paula R B Dib1, Mayara K C Fernandes1, Letícia A F Venerando2

  • 1Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Brazil.

Insights

Obesity promotes platelet activation and platelet-monocyte aggregates, contributing to inflammation and cardiovascular risk. This study reveals a reciprocal activation loop driving thromboinflammation in obese individuals.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Metabolic Disorders

Background:

  • Obesity is linked to chronic inflammation and increased cardiometabolic risk.
  • Platelets play critical roles in hemostasis, inflammation, and immunity.
  • Mechanisms of platelet-leukocyte interactions in obesity-related inflammation are not fully understood.

Purpose of the Study:

  • To investigate the role of platelet activation and platelet-leukocyte interactions in obesity-induced inflammation.
  • To elucidate the mechanisms underlying thromboinflammation in obesity.

Main Methods:

  • Observational cross-sectional study of 87 obese patients (BMI >30).
  • Co-culture models to investigate thromboinflammatory amplification mechanisms.
  • Evaluation of platelet and monocyte activation markers, including CD16 and tissue factor (TF).

Main Results:

  • Obese individuals exhibit increased platelet activation and platelet-monocyte aggregate formation.
  • Platelet-monocyte interaction leads to reciprocal activation, TF expression, and pro-inflammatory mediator secretion.
  • This activation loop is partially dependent on CD62P, CD40L, and integrin αIIb/β3 signaling.
  • Co-culture conditioned medium activates endothelial cells.

Conclusions:

  • A reciprocal platelet-monocyte activation loop contributes to thromboinflammation in obesity.
  • This loop is associated with cardiometabolic risk markers in obese patients.
  • Understanding these mechanisms offers potential therapeutic targets for obesity-related cardiovascular complications.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
63.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.2K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.3K